Presentation is loading. Please wait.

Presentation is loading. Please wait.

B. Activated CD56+ NK % CD56 + CD3 - cells% CD161 + CD3 - cells C. Activated CD161+ NK % CD56 + CD3 + cells D. Activated CD56+ NKT P=0.007 P=0.009 P=0.02.

Similar presentations


Presentation on theme: "B. Activated CD56+ NK % CD56 + CD3 - cells% CD161 + CD3 - cells C. Activated CD161+ NK % CD56 + CD3 + cells D. Activated CD56+ NKT P=0.007 P=0.009 P=0.02."— Presentation transcript:

1 B. Activated CD56+ NK % CD56 + CD3 - cells% CD161 + CD3 - cells C. Activated CD161+ NK % CD56 + CD3 + cells D. Activated CD56+ NKT P=0.007 P=0.009 P=0.02 P=0.002 P=0.003 P= P= ND A Fold Expansion (Log) P=0.04 P=0.01 P=0.72

2 F. CD3+ Cells % total of CD3 + cells G. Tm cells % Tm cells P=0.8 P=0.02 P=0.006 P=0.02 P=0.003 P=0.001 % CD161 + CD3 + cells E. Activated CD161+ NKT P=0.004 P=0.05 ND Supplemental Figure 1. Determination of cryosensitivity of the reprogrammed cells. A) Fold expansion compared to day one of IL- 2 (n=13), B/I-Fresh (n=16) and Freeze-B/I (n=11) PBMCs. Cell counts were performed using trypan blue exclusion. Data represent Least Squares Means ± SEM. B)The percentage of activated CD56+ NK cells was determined in reprogrammed cells which included B/I-Fresh (n=6), B/I-Freeze (n=9), and Freeze-B/I (n=8). C) The percentage of activated CD161+ NK cells was determined in B/I-Freeze (n=5), and Freeze-B/I (n=3). D) The percentage of activated CD56+ NKT cells was determined in B/I-Fresh (n=6), B/I-Freeze (n=9), and Freeze-B/I (n=8). E) The percentage of activated CD161+ NKT cells was determined in B/I-Freeze (n=5), and Freeze-B/I (n=3). F) The percentage of total CD3 + cells on gated lymphocyte region was determined in B/I-Fresh (n=5), B/I-Freeze (n=7), and Freeze-B/I PBMCs (n=8). G) The percentage of Tm cells was determined in B/I-Fresh (n=5), B/I-Freeze (n=7), and Freeze-B/I PBMCs (n=8). Data represent Mean ± SEM. ND = not done.

3 P=0.2 A B Reprogrammed PBMC IL-2/7/15 PBMC P=0.2 % total of CD3 + cells CD3 % Tm cells CD62L CD44 Reprogrammed PBMC IL-2/7/15 PBMC P=0.07 IL-2/7/15 D. Activated CD161+ NK CD25 Reprogrammed P=0.12 ReprogrammedIL-2/7/15 C. Activated CD56+ NK CD25 % CD56+ CD25+ NK cells % CD161+ CD25+ NK cells Supplemental Figure 2. Determination of the role of B/I in cellular reprogramming. PBMCs (n=3) were split into two groups and then subjected to reprograming protocol in the presence (Reprogrammed PBMC) or absence (IL-2/7/15 PBMC) of B/I. The frequency of (A) total CD3 + cells, (B) Tm cells, (C) activated CD56+ NK cells, and (D) activated CD161+ NK cells was determined in Reprogrammed and IL2/7/15 PBMCs using flow cytometry. Data represent Mean ± SEM.

4 Baseline IL-2/7/15 PBMCReprogrammed PBMC V 9 J2-2 A B V 5-7 J2-3 V 11-3 J2-2 C Frequency J gene Supplemental Figure 3. Bryostatin 1 and Ionomycin selectively expand specific T cell clones. High-throughput sequencing of TcR Vβ was performed from one patients PBMCs at baseline, after culture with γ-c cytokines only (IL-2/7/15 PBMC), or after reprogramming with B/I and γ-c cytokines (Reprogrammed PBMC). Representative data for the effect of reprogramming on the expansion of dominant clone (A), skewed clonality (B), or no impact on specific clones (C).


Download ppt "B. Activated CD56+ NK % CD56 + CD3 - cells% CD161 + CD3 - cells C. Activated CD161+ NK % CD56 + CD3 + cells D. Activated CD56+ NKT P=0.007 P=0.009 P=0.02."

Similar presentations


Ads by Google